Toggle Main Menu Toggle Search

Open Access padlockePrints

Clopidogrel and vascular disease prevention

Lookup NU author(s): Professor Gerard Stansby


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


In this editorial we consider some aspects of the use of clopidogrel in current clinical practice. Clopidogrel has replaced ticlopidine as an alternative to aspirin. Among the problems with the use of antiplatelet agents is aspirin intolerance. The options for these patients are discussed; these include using clopidogrel. Clopidogrel may be especially effective in patients with peripheral arterial disease. However, this impression requires confirmation in appropriately designed trials. We also consider the effect of antiplatelet agents on growth factor release by platelets and of clopidogrel on the inflammatory process. Clopidogrel is a useful, evidence-based, antiplatelet agent.

Publication metadata

Author(s): Daskalopoulou SS, Stansby G, Mikhailidis DP

Publication type: Editorial

Publication status: Published

Journal: Current Medical Research and Opinion

Year: 2004

Volume: 20

Issue: 11

Pages: 1835-1838

ISSN (print): 0300-7995

ISSN (electronic): 1473-4877


DOI: 10.1185/030079904X10656